Examples of using Analysis set in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
Full analysis set. .
Table 1: KOOS Response Rate*: Full Analysis Set.
Full Analysis Set NA not available.
Intent-to-Treat Analysis Set. .
Full analysis set, non-responder imputation for missing values.
Pharmacokinetic parameters for all subjects(full analysis set) are presented in the table below.
first two cycles for study MT103-211 primary analysis set.
so simple it seems almost trivial its analysis sets the stage for the more complex cases.
Interim Analysis Intent-to-Treat Interim Analysis Set.
Mean(+/- SEM) Pain Intensity Difference at Each Time Point(Full Analysis Set) Mean(SEM) Pain Intensity Differences.
A Full analysis set(FAS) using last observation carried forward(LOCF)
Mean(+/- SEM) Pain Intensity Difference at Each Time Point Full Analysis Set.
Efficacy outcomes at week 52 and week 100(Full Analysis Set with LOCF) in VIVIDDME and VISTADME studies.
weeks is maintained for up to 3 months but failed the primary analysis set at 6 months.
CI confidence interval; Full analysis set all randomised, treated patients analysed as allocated
Efficacy outcomes at week 24 and week 52(Full Analysis Set with LOCF) in VIBRANT study.
provided PK parameters that were included in the Per-Protocol PK analysis set.
week 52 and week 76/100(Full Analysis Set with LOCFC) in COPERNICUS and GALILEO studies.
GALILEO Studies Full Analysis Set.
computer to be managed in a variety of ways(analysis, setting, creation, storage of playback history, etc.).
A Full analysis set(FAS) using last observation carried forward(LOCF)
The seroprotection rates to measles, mumps, and rubella for the Full Analysis Set are given in Table 1.
FAS: Full analysis set, all randomized patients who took at least
and week 48 in MYRROR study Full Analysis Set with LOCFA.
The mean(± SD) and median dose of RIXUBIS in the per protocol analysis set(n=25) were 74.69±2.37 and 74.25 IU/kg,
Member State a reasoned opinion in which it adhered to the analysis set out in the letter of formal notice.
A Subgroup analysis of full analysis set(FAS) for patients on additional background of metformin-
number of patients in the analysis set; STSG Split-thickness skin graft.
During the overall study period in the ITT population(analysis set to show superiority),
The opinion builds upon the analysis set out in the recently adopted EESC opinions"Baltic Sea Region:
